Objective. Eating disorders are more common in females than in males. Gender differences may be due to organizational (i.e. prenatal) and activational (i.e. post-natal) gonadal hormone effects that influence sex differences in behavior. This preliminary set of studies examined these effects by investigating relationships between eating disorder symptoms, prenatal testosterone exposure, and adult levels of estrogen in women.
INTRODUCTION
Several epidemiologic features suggest a role for gonadal hormones in the development of anorexia nervosa (AN) and bulimia nervosa (BN). In addition to being more common in females than in males (APA, 2000) , eating disorder symptoms begin at puberty (Hayward et al. 1997 ) and tend to remit by mid-life and the menopausal years (Strober et al. 1997 ; Keel et al. 1999) . Eating disorder symptoms also show a significant heritability (>50 %) (Klump et al. 2000) , but only in girls who have reached puberty (Klump et al. 2003) , which also suggests that gonadal hormones may activate the disorders.
Animal studies extend findings by showing that gonadal hormones have both organizational (i.e. organizing neural circuitry prenatally) and activational (i.e. influencing neural systems and behavior post-natally) influences on core features of eating disorders, including food intake and physical activity. Female rats exposed to testosterone perinatally increase food intake and body weight in adulthood (Madrid et al. 1993) . In contrast to these organizing effects, circulating estrogens have activational influences that result in decreased food intake and increased physical activity in adult female rats (Dixon et al. 2003 ; Eckel, 2004) . Similar effects have been shown across a number of species including hamsters (Morin & Fleming, 1978) , guinea-pigs (Butera & Czaja, 1984) , sheep (Forbes, 1974) , and non-human primates (Bielert & Busse, 1983; Kemnitz et al. 1989) . Sex differences in food intake and body weight (i.e. males eat more and engage in less physical activity) are also controlled by organizational and activational influences of gonadal hormones in a variety of mammals (Wade, 1972) .
Based upon these data, we propose that prenatal testosterone exposure in males, which organizes sex differences in behavior of mammalian model systems (Morris et al. 2004) , reduces males' likelihood of developing eating disorders, particularly during puberty when disordered eating begins. We further propose that the rise in estrogens during puberty in vulnerable girls activates these symptoms, which are then exacerbated by circulating levels of estrogens in adulthood.
We conducted two studies investigating these hypotheses. We examined overall levels of disordered eating symptoms in menstruating women rather than AN or BN because the neuroendocrine abnormalities (amenorrhea and oligomenorrhea) that result from malnutrition and aberrant eating patterns in these disorders make it difficult to examine etiologic effects of circulating gonadal hormones versus disease sequelae. The disordered eating symptoms examined have been found to: (1) show significant sex differences (Anderson & Bulik, 2004) ; (2) be genetically associated with puberty (Klump et al. 2003) ; and (3) be significant risk factors for the development of AN and BN (Jacobi et al. 2004) . Although eating disorder symptoms in non-clinical populations could conceivably cause ovarian hormone disruptions, rather than the reverse, our focus on regularly menstruating women (see Method section) significantly decreases this possibility.
We investigated organizational effects of androgens by examining associations between finger-length ratios and disordered eating in women. Finger-length ratios [index finger (2D)/ring finger (4D)] are sexually dimorphic traits (Manning et al. 1998 ) that : (1) develop as early as the thirteenth week of gestation (Garn et al. 1975) ; (2) correlate with prenatal levels of testosterone obtained by amniocentesis (Lutchmaya et al. 2004) ; (3) are more masculinized (i.e. lower ratios) in men and women with congenital adrenal hyperplasia (CAH) who have high prenatal levels of androgens Okten et al. 2002) ; and (4) are associated with other behavioral phenotypes that show significant sex differences (e.g. aggression) (Manning et al. 2000 ; Manning, 2002 ; Bailey & Hurd, 2005) . Given the difficulty of obtaining prospective prenatal measures of hormone exposure in humans, finger-length ratios are considered one of the most robust measures of prenatal androgen effects (Manning, 2002 ; Lutchmaya et al. 2004) .
We also examined activational influences by investigating relationships between circulating levels of estradiol and the same disordered eating symptoms in two independent samples of adult women.
METHOD
Written informed consent was obtained from all participants after study procedures were explained. Samples in both studies were recruited from the community ; thus, subjects were not screened for the presence or absence of an eating disorder or any other form of psychopathology. Klump et al. 2000) # was used to assess overall levels of disordered eating symptoms. The MEBS assesses levels of body dissatisfaction, weight preoccupation, binge eating, and compensatory behaviors. Higher scores indicate more disordered eating. The MEBS shows good psychometric properties (Klump et al. 2000) and successfully differentiates between women with AN and BN and controls.
Finger-length ratios. Finger-length ratios were calculated from measurements made with a standard ruler (in centimeters) of photocopies of the hands. A template was used for photocopies to ensure standard hand position for all subjects. One research assistant conducted all of the initial measurements of 2D and 4D. A second rater scored a subsample of copies (n=36 copies of both hands) and achieved excellent inter-rater reliability on the 2D and 4D measurements with the initial rater (all intra-class r's>0 . 97). In addition, measurements of fingers from hand photocopies showed excellent convergence with in-person measurements of finger lengths (all r's>0 . 90 ; n=15) and with X-rays of hands in previous research (Manning et al. 2000) . Lower 2D : 4D ratios suggest greater prenatal androgen exposure (Manning et al. 1998; Brown et al. 2002) .
Statistical analyses
Associations between disordered eating and finger-length ratios were examined using Pearson correlations. Given previous research showing ethnic differences in finger-length ratios , correlations were conducted within the entire sample as well as within Caucasian subjects only. Results were essentially identical (data not shown), and thus only correlations within the full sample are reported.
Study 2 : Activational influences Participants Sample 1 included 24 females (mean age=19 . 52 years, S.D.=0 . 88, range=18-21 years) recruited through a volunteer research pool at a large university. Sample 2 included 25 adult female twin individuals (mean age=21 . 43 years, S.D.= 1 . 79, range=18-25 years) who were participating in a Michigan State University twin study that was unrelated to that used for Study 1. Participants in both samples were mainly of Caucasian ancestry (>70 %).
All participants were required to have regular menses (defined as no skipped periods in the past 6 months and no more than two total skipped cycles in the 6 months preceding) and to be free from oral contraceptive use, hormonal treatment, cigarette use, steroid medication use, and medical conditions known to influence steroid hormone functioning.
Assessments
Disordered eating. The MEBS total score was used to assess disordered eating.
Body mass index. Body mass index [BMI; weight (kg)/height 2 (m)] was calculated using height and weight measurements made with a wall-mounted metric ruler and digital scale, respectively.
Estradiol. Salivary estradiol samples were collected using salivettes at 08.30 hours after an overnight fast (i.e. no food or drink) in the follicular phase of the menstrual cycle (i.e. days 1-3 after the cessation of menses). Samples were frozen and subsequently analyzed by Salimetrics, Inc. (State College, PA, USA). Radioimmunoassay (RIA) techniques were used for analyzing specimens from sample 1. The RIA test (Diagnostic Systems Laboratory, Webster, TX, USA) uses 300 ml of saliva sample per tube. The lower limit of sensitivity is 0 . 25 pg/ml, range of standard curve from 0 . 375 pg/ml to 7 . 5 pg/ml and average intra-and interassay coefficients of variation of less than 6 . 45 % and 9 . 0 % respectively. Method accuracy, determined by spike recovery, and (Shirtcliff et al. 2000) .
By contrast, an enzyme immunoassay (EIA) was used for analyzing sample 2 as this technique requires lower sample volumes. Saliva samples (150 ml) were diluted 1 : 2 in assay diluent and well mixed. A 100 ml aliquot of diluted sample was then pipetted into individual wells of a 96-well microtiter plate. The estradiol lower limit of sensitivity is 1 pg/ml, range of standard curve from 2 pg/ml to 64 pg/ml, and average intra-and interassay coefficients of variation of 5 . 75 % and 6 . 87 % respectively. Method accuracy, determined by spike recovery, and linearity, determined by serial dilution, averaged 103 . 9% and 103 . 5 % respectively. Estradiol results determined using the EIA protocol are highly correlated [r(50)=0 . 97, p<0 . 0001] with those returned using the RIA method described above.
Statistical analyses
Estradiol values are reported in picograms/ milliliter and were log transformed due to positive skew. Because body weight has been strongly and consistently shown to correlate with estradiol levels (Wade, 1972) , partial correlations were used to examine relationships between estradiol levels and disordered eating, partialling out BMI. We also examined whether symptoms of depression (assessed with the Beck Depression Inventory; Beck & Steer, 1987) and anxiety (assessed with the Spielberger State Trait Anxiety Inventory ; Spielberger et al. 1970) influence associations. Overall, partial correlations indicated that neither depression nor anxiety consistently influenced estradiol/ disordered eating relationships (data not shown). Thus, we focus on partial correlations that account for BMI only in the results reported here. Table 1 includes descriptive statistics for MEBS total scores, finger-length ratios, estradiol levels, and BMIs for study subjects. The MEBS total scores were in the mild to moderate range across all samples, although the scope of scores (0-25 in Study 1 ; 2-23 and 0-14 in samples 1 and 2 respectively from Study 2) was broad and included scores in the severe range. Indeed, 13-26 % of the subjects across studies scored above the mean for eating disorder subjects (mean=12 . 00) (Klump et al. 2000) . Means of other variables were either similar to previous research (i.e. finger-length ratios ; Manning, 2002) or similar across samples (e.g. BMI).
RESULTS
Given our unidirectional hypotheses, onetailed p values were used for all analyses.
Study 1
Pearson correlations examining relationships between finger-length ratios and disordered eating were significant (right 2D : 4D, p=0 . 005; left 2D : 4D, p=0 . 006) and in the predicted direction (see Fig. 1 ). These findings indicate that lower levels of prenatal androgen exposure are associated with increased eating disordered symptoms.
Study 2
Partial correlations between disordered eating and estradiol levels were of moderate effect sizes (Cohen, 1988) and showed positive associations between estradiol levels and disordered eating in both samples (sample 1, p=0 . 05 ; sample 2, MEBS, Minnesota Eating Behavior Survey ; 2D : 4D, length of index (second digit) finger (in cm) divided by the length of the ring (fourth digit) finger (in cm); BMI, body mass index [weight (kg)/ height 2 (m)] ; estradiol, salivary estradiol (pg/ml). Differences in means between sample 1 and sample 2 estradiol levels can be accounted for by differences in assay techniques (i.e. radioimmunoassay for sample 1 and enzyme immunoassay for Study 2).
p=0 . 07) (see Fig. 2 ). The combined probability of this covariation occurring by chance alone in the two samples is 0 . 005, indicating that higher circulating levels of estrogens increase the probability of disordered eating.
DISCUSSION
Both the organizational and activational effects described above would be expected to make eating disorders more common in females than in males, suggesting that gonadal hormones may affect disordered eating symptoms known to increase the risk for AN and BN (Jacobi et al. 2004) . The mechanism of these effects remains unclear ; they could be direct (i.e. gonadal hormones directly organize and activate predispositions to disordered eating symptoms) or indirect (i.e. gonadal hormones influence body fat compositions, appetitive characteristics, etc. that then increase risk for engaging in disordered eating practices). However, developmental twin studies (Klump et al. 2003) showing the activation of genetic effects on disordered eating during puberty indicate that at least some of the gonadal hormone influences may be genetically mediated. Thus, speculative hypotheses about the nature of the genetic effects are warranted. In animal models, early androgen exposure characteristic of males makes the brain less responsive to estrogens in adulthood. For example, female rodents and primates exposed perinatally to testosterone are much less likely to display sexual receptivity as adults, even if supplied with exogenous estrogen (Phoenix et al. 1959 ; Thornton & Goy, 1986) . Our findings suggest that part of the genetic diathesis for eating disorders may be organized by relatively low prenatal exposure to androgen typical of females and then activated at puberty and maintained in adulthood by circulating estrogens.
The activated genetic influence may be related to genes encoding for the estrogen receptors or neuronal systems that are influenced by circulating estrogens. A significant association between a particular variant of the estrogen receptor beta (ERb) gene and AN (Eastwood et al. 2002) and BN (Nilsson et al. 2004 ) has been reported, although some conflicting findings exist (Rosenkranz et al. 1998) . The altered function of this variant may be revealed when estrogen levels rise during puberty. ERb plays a key role in the anorexic effects of estrogen on food intake in rats ; selective inhibition of ERb blocks the ability of exogenous estrogen to reduce food intake (Liang et al. 2002) . These ERb functions may operate through the paraventricular nucleus (PVN) of the anterior hypothalamus, which is involved in the estrogen-mediated influences on food intake and body weight. Indeed, ERb is the predominant estrogen receptor in the PVN, regulating most estrogen-mediated neuroendocrine activities in this region in mice (Zhang et al. 2004) .
Estrogen may also affect eating pathology by influencing the function of neurotransmitters. Alterations in serotonergic functioning have been repeatedly linked to eating disorders with several studies suggesting a particular association with the 5-HT2A receptor (Frank et al. 2002 ; Bailer et al. 2004 ). This receptor is more sensitive to estrogen regulation than others (Ostlund et al. 2003) and shows the strongest association with AN of any candidate gene examined to date (Gorwood et al. 2002; Klump & Gobrogge, 2005) .
Taken together, our preliminary data suggest a speculative, yet intriguing hypothesis -that the genetic diathesis of disordered eating is organized by prenatal androgens, triggered by the rise in estrogens during puberty in girls, and exacerbated throughout adulthood by circulating estrogens. This genetic effect may be related to estrogen-regulated genes that eventually lead to disordered eating symptoms that increase risk for full syndromal AN and BN. This theory remains largely untested, as our data only provide preliminary support for organizational and activational hormone effects. We hope that future research will examine this hypothesis directly to determine its relevance for the etiology and genetic diathesis of eating disorders.
Several limitations of our studies should be noted. First, sample sizes in our estradiol studies were small. Nonetheless, the correlations represent moderate effect sizes and were replicated across two independent samples of women, suggesting that they are clinically significant and robust. Second, because this was a pilot study, we used single assessments of hormones during one phase of the menstrual cycle. Additional research is needed to determine whether similar phenotypic associations are present across menstrual cycle phases. Preliminary efforts in this realm have been promising (e.g. Lester et al. 2003) .
Third, we did not examine circulating levels of testosterone in the adult women. Some research has suggested that women with polycystic ovary syndrome (PCOS) might have increased rates of BN in adulthood (Raphael et al. 1995 ; Morgan et al. 2002) . PCOS is associated with increased circulating levels of testosterone as well as increased levels of estradiol (Mitwally & Casper, 2004 ; Carmina et al. 2005 ; Gadducci et al. 2005) . It is possible that binge eating in these subjects is associated with increased estradiol levels (rather than testosterone) that result from anovulation (Carmina et al. 2005) as well as the aromatization of testosterone into estradiol (Geary, 2001 ; Hirschberg et al. 2004 ; Mitwally & Casper, 2004) . Examining associations between testosterone, estradiol and disordered eating in adult women without PCOS would be the first step in examining this possibility. Although some animal research suggests that PCOS might be associated with increased prenatal exposure to testosterone (Abbott et al. 2002) , and thus BN might also be associated with increased exposure, the PCOS animal model has not been extended to humans (Dumesic et al. 2005) and our data did not show this association. In fact, our data confirmed our hypothesis of decreased prenatal androgen exposure correlating with increased levels of disordered eating. More work is needed to replicate these associations and clarify their meaning for relationships between testosterone, PCOS and eating disorders.
A fourth limitation of our study is that we focused on circulating levels of estradiol in adult women rather than girls during the pubertal period. Future longitudinal research is needed to confirm that the rise in estrogens during puberty activates the disordered eating symptoms and their genetic diathesis. Fifth, we examined eating disorder symptoms rather than clinical eating disorders. However, the symptoms investigated are some of the strongest prospective predictors of AN and BN (Jacobi et al. 2004) , suggesting that they indeed have relevance for the clinical syndromes. In addition, the neuroendocrine abnormalities that result from AN and BN (i.e. attenuated ovarian hormone functioning) make it difficult to examine activational hormone influences in women who are already ill with these conditions. Although it is possible that subsyndromal symptoms may influence hormone levels, the direction of effects would be the opposite (i.e. depressed estradiol levels correlating with eating disorder symptoms) to what we observed.
Finally, our hypothesis of genetic mediation of hormone influences remains to be tested. Additional twin and molecular genetic studies that directly test this hypothesis for a range of eating disorder symptoms and syndromes are needed to confirm our theory of genetic mediation of observed effects.
